| 2009-December-21 |
Mesoblast - National Electronic Media Coverage (in PDF) |
| 2009-December-18 |
Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes (in PDF) |
| 2009-November-30 |
A Year of Solid Progress Address by Mesoblast Chairman, Mr Brian Jamieson; 2009 Annual General Meeting (in PDF) |
| 2009-November-18 |
Sustained Six-Month Improvement in Heart Muscle Function by "off-the-shelf" Adult Stem Cells (in PDF) |
| 2009-November-6 |
Successful Bone Marrow Regeneration in Cancer Patients Using Cord Blood Expanded by Proprietary Stem Cells (in PDF) |
| 2009-October-28 |
Notice of 2009 Annual General Meeting (in PDF) |
| 2009-October-26 |
The CEO Transcript - Investor Briefing with Silviu Itescu, Executive Director, Mesoblast Limited (in PDF) |
| 2009-October-16 |
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) |
| 2009-October-12 |
Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) |
| 2009-October-6 |
Form 605 - Notice of Ceasing to be a Substantial Holder (in PDF) |
| 2009-September-30 |
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) |
| 2009-September-24 |
UBS Life Sciences Investor Conference in United States Features Associate Company Angioblast (in PDF) |
| 2009-September-22 |
Enrolment Complete for Second Group of Heart Failure Patients Treated with "Off-The-Shelf" Adult Stem Cells (in PDF) |
| 2009-September-15 |
Mesoblast Disc Repair Results Highlighted at Key Orthopaedic Conference (in PDF) |
| 2009-September-10 |
Mesoblast's Proprietary Stem Cells Successfully Repair/Regenerate Damaged Intervertebral Disc Cartilage (in PDF) |
| 2009-September-1 |
The CEO Transcript - Investor Briefing with Silviu Itescu, Executive Director, Mesoblast Limited (in PDF) |
| 2009-August-26 |
Appendix 4E - Preliminary Final Report Year Ending on 30 June 2009 (in PDF) |
| 2009-August-26 |
Financial Year End Results, Mesoblast Delivers on Broadening Product Portfolio (in PDF) |
| 2009-August-25 |
United States Associate Company Angioblast Closes $10M Equity-Based Financing (in PDF) |
| 2009-August-19 |
Mesoblast's Associate Company, Angioblast Systems, Secures New Capital (in PDF) |
| 2009-August-17 |
Mesoblast Gains US FDA Clearance for Phase 2 Trial in Minimally Invasive Lumbar Spinal Fusion Surgery (in PDF) |
| 2009-August-5 |
Proprietary Technology in World-First Allogeneic Stem Cell Trial for Treatment of End-Stage Heart Failure in Patients Supported by Mechanical Heart Assist Devices (in PDF) |
| 2009-July-30 |
Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) |
| 2009-July-30 |
Letter from the Chairman (in PDF) |
| 2009-July-23 |
Mesoblast to Apply for Regulatory Approval of its Bone Fracture Repair Products (in PDF) |
| 2009-June-30 |
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) |
| 2009-June-26 |
Mesoblast Featured on ABC-TV's Catalyst Program (in PDF) |
| 2009-June-24 |
First Patients in Bone Marrow Transplant Trial Show Earlier Engraftment (in PDF) |
| 2009-May-14 |
Heart Muscle Function Improved Significantly after Single, Lowest-Dose Injection of "off-the-shelf" Stem Cells in Patients with Heart Failure (in PDF) |
| 2009-May-5 |
Letter from the Chairman (in PDF) |
| 2009-May-1 |
Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) |
| 2009-April-28 |
Mesoblast Commences Clinical Program for Fusion of Cervical Spine (in PDF) |
| 2009-April-8 |
Form 603 - Notice of Initial Substantial Holder (in PDF) |
| 2009-April-7 |
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) |
| 2009-April-2 |
Form 604 - Notice of Change of Interests of Substantial Holder (in PDF) |
| 2009-April-2 |
Section 708A Notice - Issue of Shares Under Private Placement to Wholesale Investors (in PDF) |
| 2009-April-2 |
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) |
| 2009-March-30 |
Mesoblast Raises Capital for New Clinical Programs (in PDF) |
| 2009-March-26 |
Trading Halt (in PDF) |
| 2009-March-23 |
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) |
| 2009-February-27 |
Mesoblast Results Highlighted at Key Orthopaedic Conferences (in PDF) |
| 2009-February-26 |
Half-Year Results, Emerging Portfolio of Clinical Products Underpin Commercial Strategic Objectives (in PDF) |
| 2009-February-26 |
Appendix 4D - Half Year Report for the Six months to 31 December 2008 (in PDF) |
| 2009-February-25 |
First Group of Heart Failure Patients Treated with "Off-The-Shelf" Adult Stem Cells Successfully Pass Key Safety Milestone (in PDF) |
| 2009-February-16 |
ParkwayHealth and Mesoblast to Provide Cutting Edge Treatment Using Proprietary Adult Stem Cells (in PDF) |
| 2009-January-30 |
Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) |
| 2009-January-20 |
Mesoblast Stem Cells Approved for World First Osteoarthritis Clinical Trial (in PDF) |
| 2009-January-6 |
Mesoblast Named 2009 North American Emerging Company by Frost & Sullivan (in PDF) |
| 2017 |
2017 Announcements / Press Releases |
| 2016 |
2016 Announcements / Press Releases |
| 2015 |
2015 Announcements / Press Releases |
| 2014 |
2014 Announcements / Press Releases |
| 2013 |
2013 Announcements / Press Releases |
| 2012 |
2012 Announcements / Press Releases |
| 2011 |
2011 Announcements / Press Releases |
| 2010 |
2010 Announcements / Press Releases |
| 2008 |
2008 Announcements / Press Releases |
| 2007 |
2007 Announcements / Press Releases |
